{"output": [["Simcere Pharmaceutical Group", "COMP", "Announce", "Strategic Collaboration", "CONCEPT"], ["Simcere Pharmaceutical Group", "COMP", "Control", "Multiple Bispecific Antibodies", "PRODUCT"], ["Merus", "COMP", "Grant", "Exclusive License", "CONCEPT"], ["Merus", "COMP", "Operate_In", "China", "GPE"], ["Merus", "COMP", "Relate_To", "Biclonics Technology Platform", "CONCEPT"], ["Merus NV", "COMP", "Get", "Upfront & Milestone Payments", "FIN_INSTRUMENT"], ["Merus NV", "COMP", "Control", "Certain Specified Development & Commercial Goals", "CONCEPT"], ["Merus NV", "COMP", "Receive", "Tiered Royalty Payments", "FIN_INSTRUMENT"], ["Simcere", "COMP", "Receive", "Tiered Royalty Payments", "FIN_INSTRUMENT"], ["Simcere", "COMP", "Operate_In", "Outside of China", "GPE"]], "published": "2018-01-08T20:08:00.000+02:00"}